Skip to main content
Biogen8-K: Acquisition completed

Biogen Closes Acquisition of RayThera Inc. Recording $284M in Upfront and IPR&D Expenses

Source: Autobound Signal API · 76 signals tracked for Biogen · updated

Get Biogen's live signals in Claude or ChatGPT, or by API

AskWhat changed at Biogen this week? Use Autobound signals for biogen.com.

What happened

Biogen incurred $284 million of acquired IPR&D, upfront and milestone expense in Q3 2026 primarily related to the stock acquisition of RayThera Inc.

Source

SEC EDGAROct 28, 2026

Current report (Form 8-K)

Biogen 8-K

Filing excerpt

Third quarter 2026 GAAP and Non-GAAP diluted EPS include $284 million of acquired IPR&D, upfront and milestone expense, primarily related to the acquisition of RayThera Inc. as compared to $2 million in the third quarter of 2025.

sec.gov/Archives/edgar/data/875045/000087504526000094/biib-20261028.htmRead the full source

Other signals in this filing (1)

Extracted by Autobound

From the Signal API record
Signal
8-K: Acquisition completed

What this signalsIntegration work after a deal often opens needs for new systems and services.

Form
8-K
Fiscal year end
10/28
Filed
Oct 28, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$284M (acquired IPR&D, upfront and milestone expense primarily related to RayThera Inc. acquisition)

Details

CIK
875045
Accession number
0000875045-26-000094
Timeframe
Current quarter
Filing year
2026
Why it matters
Active integration needs
Signal category
Strategic

Extraction

Confidence
High
Relevance
85%
Sentiment
Neutral
Detected
Nov 3, 2026
signal_type
sec-8k
signal_subtype
acquisitionCompleted

Use this data

Get every 8-K signal for Biogen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/e7b3368d-0230-48dc-b86f-78e9bdae7d69 returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.

{
  "signal_id": "e7b3368d-0230-48dc-b86f-78e9bdae7d69",
  "signal_type": "sec-8k",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-11-03T07:06:53.854+00:00",
  "company": {
    "name": "Biogen",
    "domain": "biogen.com"
  },
  "data": {
    "detail": "Biogen incurred $284 million of acquired IPR&D, upfront and milestone expense in Q3 2026 primarily related to the stock acquisition of RayThera Inc. Integration of newly acquired pipeline assets may create opportunities for clinical development, regulatory compliance, and post-merger integration service vendors.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "acquired IPR&D, upfront and milestone expense primarily related to RayThera Inc. acquisition",
      "dollar_millions": 284
    },
    "summary": "Biogen Closes Acquisition of RayThera Inc. Recording $284M in Upfront and IPR&D Expenses",
    "excerpts": "Third quarter 2026 GAAP and Non-GAAP diluted EPS include $284 million of acquired IPR&D, upfront and milestone expense, primarily related to the acquisition of RayThera Inc. as compared to $2 million in the third quarter of 2025.",
    "relevance": 0.85,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000094/biib-20261028.htm",
    "filing_date": "2026-10-28",
    "filing_year": 2026,
    "fiscal_year_end": "10/28",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.